CION Ameerpet
Prognosis & Recurrence · Reviewed by CION Oncologists · NABH Accredited
Living With Advanced Endometrial Cancer
You are probably here looking for a number, so let us deal with that first, honestly. Nobody can tell you how long, and anyone who offers a confident figure is not being straight with you. Advanced endometrial cancer covers situations that differ enormously — in how much disease there is, where it is, what type it is, what the molecular profile shows, and how it responds to the first treatment. Published statistics average all of that together and describe women treated years ago. What can be answered is what your treatment is for, what is likely in the coming months, and what makes living with this easier. That is what this page is about.
- Nobody can give you a reliable number — and confident figures are not honest ones
- It is treated actively — and the options have genuinely expanded
- Molecular testing matters most here — it determines what is available
- Palliative care is not end-of-life care — the most useful correction on this page
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Why Nobody Will Give You a Number
Not evasion. Five reasons the question genuinely does not have the answer you are looking for.
- “Advanced” covers enormously different situations. Disease in a few lymph nodes and disease throughout the abdomen and lungs are both advanced. Averaging them produces a figure that describes neither.
- Response to treatment is the biggest variable and it is not knowable in advance. Some women respond well and durably; some do not. That divergence appears after treatment starts, not before, which is why the honest answer early is “let us see how you respond”.
- Molecular profile changes what is available. A mismatch repair deficient tumour has treatment avenues a proficient one does not, and outcomes in that group have changed substantially. Statistics gathered before those treatments existed cannot reflect this. See MMR and MSI testing.
- Published figures are historical. Five-year data describes women diagnosed at least five years ago, and treatment for advanced endometrial cancer has changed meaningfully in that time.
- Averages say nothing about individuals. A median is the middle of a wide spread. Half the women in any group do better than it, some considerably so, and no figure tells you where you sit.
What your oncologist can tell you is what the treatment is intended to achieve, what is likely over the next few months, and what would prompt a change of plan. Those are answerable questions and they are more useful than a number would be. See is endometrial cancer terminal.
Did You Know? The single most useful correction available to anyone with advanced cancer concerns palliative care, because the phrase is almost universally misunderstood. It does not mean treatment has been stopped, and it does not mean the end is near. Palliative care specialists manage pain, sickness, appetite, fatigue and distress alongside active anticancer treatment, and the evidence is that involving them early improves symptom control and quality of life — and helps people tolerate their cancer treatment better. Being referred is not a signal about your prognosis. Declining a referral because of what the word sounds like is one of the commonest ways people make their own months harder than they needed to be. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms and Palliative Care; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; ASCO guidance on integration of palliative care into standard oncology care.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What Actually Shapes Your Situation
The things that genuinely differ between women with advanced disease.
| Factor | Why it matters |
|---|---|
| Molecular profile | The most consequential single thing to establish. Mismatch repair status determines access to whole classes of systemic treatment. If it was never done on your original tumour, it can nearly always be done on stored tissue — and it is the most commonly missed step. |
| How much disease, and where | Disease confined to lymph nodes differs from disease at multiple distant sites. Whether a single site can be treated locally alongside systemic treatment is a real question worth asking. |
| Histological type | Endometrioid, serous, clear cell and carcinosarcoma behave differently and respond differently. See Type 2 prognosis. |
| Response to first-line treatment | The strongest indicator of what follows, and it emerges only once treatment has begun. This is the honest reason for the wait-and-see answer at the start. |
| Your general health | Determines what treatment you can be given and how well you tolerate it. It is also the factor most amenable to being actively supported — nutrition, symptom control and activity all feed into it. |
| Symptom control | Not merely comfort. Pain, sickness and poor appetite reduce what treatment you can tolerate, so controlling them properly affects what is possible. See nutrition. |
If nothing else comes of reading this page, establish your molecular profile. Mismatch repair status in advanced endometrial cancer is the gateway to systemic options that did not exist a decade ago. A tumour that has never been tested sits outside those conversations, and nobody will look for what has not been established.
Has Your Tumour Been Profiled?
If not, it can nearly always be done on stored tissue — and in advanced disease it determines what is available.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Palliative Care Is Not End-of-Life Care
It runs alongside active treatment, improves symptoms and quality of life, and helps you tolerate therapy better.
What Genuinely Helps
Practical, and each of these is something you can ask for.
Early palliative care, alongside treatment
The most under-used intervention in advanced cancer. Specialists in symptom control managing pain, sickness, appetite, fatigue and distress while your anticancer treatment continues. Involving them early improves quality of life and helps people tolerate treatment better. Ask for the referral rather than waiting to be offered it, and do not read it as a signal about your prognosis.
Treating symptoms properly rather than enduring them
Pain, nausea, constipation, breathlessness and fatigue are all treatable, and enduring them quietly reduces what treatment you can tolerate. Report them specifically and early — "I have been struggling" is less useful than "the pain wakes me at night and paracetamol is not touching it".
Nutrition taken seriously
Maintaining weight and strength affects how well you tolerate treatment and how you feel day to day. This is not the time for restrictive diets or regimes found online; ask for dietetic input. See nutrition.
Gentle activity, within what you can manage
Counter-intuitive and well supported: graded gentle activity reduces cancer-related fatigue more reliably than rest does. Not exercise in any demanding sense — walking, moving regularly, keeping some strength. See exercise.
Practical and financial planning, early
Getting insurance, employment, and family arrangements sorted while you feel relatively well is easier than doing it later, and it removes a background source of stress. It is a practical task rather than a statement about expectations. See insurance and cover.
Want Every Option Looked At Again?
Bring your reports. Molecular testing completed if needed, and your case taken to a full board. The opinion is free.
Questions Worth Asking Your Oncologist
These have answers, in a way that “how long” does not.
- “What is this treatment intended to achieve?” Shrinking the disease, holding it steady, relieving a symptom. Knowing the aim lets you judge whether it is working on its own terms rather than against an unstated hope.
- “What is my molecular profile, and did it change the plan?” If it has not been established, ask for it to be. If it has, ask what it opened or closed.
- “What are the next options after this one?” Knowing there is a next line, and what it is, changes how the current one feels. Ask also about clinical trials, which are a legitimate part of the conversation rather than a last resort.
- “What should I be watching for between appointments?” And whom to ring, and how fast you will be seen. Converting vague dread into a defined procedure genuinely reduces it.
- “Can I be referred to palliative care alongside this?” Ask for it explicitly. Many oncologists welcome the request and some wait to be asked because they know how the phrase lands.
Why Advanced Disease Needs More Than One Opinion
The options span three specialties and have changed substantially. This is where a fresh review most often finds something.
Tumour board for every diagnosis
MMR / MSI testing as standard
Psycho-oncology and nutrition on the team
Survivorship care that is actually offered
Costs explained before you commit
Second opinions welcomed, not resented
Take The Next Step
Ask What the Treatment Is For
It is a question with an answer — unlike the one you came here to ask.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Living With Advanced Disease — Frequently Asked Questions
How long do people live with advanced endometrial cancer?
Nobody can give you a reliable answer, and a confident figure would not be an honest one. "Advanced" covers situations that differ enormously — disease in a few lymph nodes and disease throughout the abdomen and lungs are both advanced, and averaging them describes neither. Response to treatment is the largest variable and it emerges only after treatment begins. Published statistics describe women diagnosed years ago, before current molecular testing and systemic treatments existed. What your oncologist can tell you is what your treatment is intended to achieve, what is likely over the coming months, and what would prompt a change of plan.
Is advanced endometrial cancer treatable?
Yes, and it is treated actively rather than managed passively. Systemic treatment is the backbone — combination chemotherapy, frequently now with immune checkpoint inhibition — with targeted classes used subsequently. Surgery and radiotherapy retain roles for controlling disease at particular sites and for relieving symptoms. What has changed most is molecular characterisation: mismatch repair status determines access to classes of treatment that did not exist a decade ago and has meaningfully altered outcomes for some women. Treatment aims at controlling the disease and maintaining quality of life, and both are realistic goals.
What is palliative care, and does it mean treatment is stopping?
No, and this is the most useful correction on this page. Palliative care is specialist symptom control — managing pain, sickness, appetite, fatigue and distress — provided alongside active anticancer treatment, not instead of it. Involving palliative care early in advanced cancer improves symptom control and quality of life, and helps people tolerate their cancer treatment better. A referral is not a signal about your prognosis and it does not mean anything is being withdrawn. Declining one because of what the phrase sounds like is a common way people make their own months harder than necessary.
What is the single most useful thing I can do?
Establish your tumour's molecular profile if it has not been done. Mismatch repair status in advanced endometrial cancer is the gateway to whole classes of systemic treatment, and a tumour that has never been tested sits outside those conversations entirely — nobody looks for options that have not been made available. It can nearly always be performed on tissue stored from your original biopsy or operation, and it is the step most commonly missed. After that: ask for early palliative care alongside your treatment, and report symptoms specifically rather than enduring them.
Should I get a second opinion?
Advanced disease is where a second opinion most often changes something. The options span surgery, radiotherapy and systemic treatment; the sequence is a genuine judgement; molecular profile may not have been established; and this area has changed substantially in a short period, so a recommendation based on practice from a few years ago may not reflect what is now available. Bring your complete treatment history, your imaging and your pathology reports, and ask specifically what molecular testing has been done and what systemic options your profile makes available.
Medical disclaimer: This page provides general information about living with advanced endometrial cancer, reviewed by a CION oncologist. It is not a substitute for individual medical advice. Individual prognosis cannot be predicted from published statistics, which describe groups of patients treated in the past. Treatment options depend on disease extent, histological type, molecular findings, previous treatment and general health, and should be discussed with your treating team.